Oculis Holding AG (OCS) Other Gross PP&E Adjustments (2022 - 2026)
Quarterly Other Gross PP&E Adjustments fell 150.33% to -$2.4 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$2.4 million through Mar 2026, down 150.33% year-over-year, with the annual reading at -$2.4 million for FY2025, 130.31% down from the prior year.
Oculis Holding AG's Other Gross PP&E Adjustments history spans 5 years, with the latest figure at -$2.4 million for Q1 2026.
- Other Gross PP&E Adjustments came in at -$2.4 million for Q1 2026, up from -$2.4 million in the prior quarter.
- In the past five years, Other Gross PP&E Adjustments ranged from a high of -$526474.5 in Q4 2023 to a low of -$2.6 million in Q3 2025.
- The 5-year median for Other Gross PP&E Adjustments is -$949862.0 (2025), against an average of -$1.3 million.
- Year-over-year, Other Gross PP&E Adjustments skyrocketed 46.76% in 2025 and then crashed 150.33% in 2026.
- Oculis Holding AG's Other Gross PP&E Adjustments stood at -$786820.6 in 2022, then surged by 33.09% to -$526474.5 in 2023, then plummeted by 99.04% to -$1.0 million in 2024, then crashed by 130.31% to -$2.4 million in 2025, then increased by 1.48% to -$2.4 million in 2026.
- Per Business Quant, the three most recent readings for OCS's Other Gross PP&E Adjustments are -$2.4 million (Q1 2026), -$2.4 million (Q4 2025), and -$2.6 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Gross PP&E Adjustments (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | -83,048.00 |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | -60,691.22 |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | -285.20 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | -892,000.00 |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | -1.69 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | - |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | -189.30 Mn |
| 10 | Oculis Holding AG | 24.51 Bn | 24.21 Bn | - | -2.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.38 Mn |
| Mar 31, 2026 | -2.38 Mn |
| Dec 31, 2025 | -2.41 Mn |
| Dec 31, 2025 | -2.41 Mn |
| Sep 30, 2025 | -2.56 Mn |
| Sep 30, 2025 | -2.56 Mn |
| Jun 30, 2025 | -862,433.62 |
| Jun 30, 2025 | -862,433.62 |
| Mar 31, 2025 | -949,861.96 |
| Mar 31, 2025 | -949,861.96 |
| Dec 31, 2024 | -1.05 Mn |
| Dec 31, 2024 | -1.05 Mn |
| Sep 30, 2024 | -1.60 Mn |
| Sep 30, 2024 | -1.60 Mn |
| Jun 30, 2024 | -1.62 Mn |
| Jun 30, 2024 | -1.62 Mn |
| Mar 31, 2024 | -823,745.58 |
| Mar 31, 2024 | -823,745.58 |
| Dec 31, 2023 | -526,474.54 |
| Dec 31, 2023 | -526,474.54 |
| Sep 30, 2023 | -903,457.75 |
| Sep 30, 2023 | -903,457.75 |
| Jun 30, 2023 | -928,666.58 |
| Jun 30, 2023 | -928,666.58 |
| Dec 31, 2022 | -786,820.61 |
| Dec 31, 2022 | -786,820.61 |